Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1985-04-26
1988-05-24
Terapane, John F.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 14, 2604025, 422 61, 424 9, A61K 4300, A61K 4902, A61K 4900, C07C14923
Patent
active
047465050
ABSTRACT:
A bisamide-bisthiol ligand containing fatty acid substituted thiol useful for producing Tc-labelled radiodiagnostic imaging agents is described. The ligand forms a complex with the radionuclide .sup.99m Tc suitable for administration as a radiopharmaceutical to obtain images of the heart for diagnosis of myocardial disfunction.
REFERENCES:
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4673562 (1987-06-01), Davison et al.
Davison et al., Inorg. Chem., 20:6, pp. 1629-1632, (1981).
Fritzberg et al., J. Nucl. Med. 22:258-263, (1982).
Jones, A. et al., "Chemical and In Vivo Studies of the Anion Oxo [N,N'-Ethylenebis(2-Mercaptoacetimido)]Technetate(V)", J. Nucl. Med., 23:9 pp. 801-809 (82).
Fritzberg, A. et al., "Synthesis & Biological Eval. of Tc-99m N,N'-Bis(Mercaptoacetyl)-2,3-. . . o-Iodohippurate", J. Nucl. Med., 23:7, pp. 592-598 (1982).
Fritzberg, W. P. et al., "Tc-99m Complexes Based on Diamide Dimercaptide Donor Groups (N.sub.2 S.sub.2) . . . Renal Function Agents", J. Nucl. Med., 23:5, p. 17 (1982).
Fritzberg, A. R. et al., "Chemical & Biological Studies of Tc-99m-N,N'-Bis(Mercaptoacetamido) . . . I-131-Hippuran", J. Nucl. Med., 22:6, p. 52 (1981).
Fritzberg, A. R. et al. "Renal Transport Mechanism Studies of Tc-99m-N,N'-Bis(Mercaptoacetamido)Ethylenediamine", J. Nucl. Med., 22:6, p. 51 (1981).
Klingensmith, W. C. et al., "Clinical Comparison of Tc-99m-N,N-Bis(Mercaptoacetamido)ethylenediamine (Tc-DADS) . . . Renal Tubular Function" J. Nucl. Med, 22:6, p. 38 (81).
Klingensmith, W. C. et al., "Clinical Evaluation of Tc-99m,N,N'-Bis(Mercaptioacetyl)2,3-Diaminopropanoate . . . for I-131-Hippuran" J. Nuc. Med. 24:5, p. 80 (1983).
Byrne, E. et al. "Technetium-99m Bifunctional Chelating Agent . . . to Technetium", Society of Nuc. Med., 30th Annual Meeting, Jun. 7-10, 1983.
Subramanian, G. et al., "An Evaluation of 16 New Tc-99m Compounds for Renal Tubular Excretion Studies", J. Nucl. Med. 24:5, p. 80 (1983).
Costello, C. E. et al "The Investigation of Radiopharmaceutical Components by Fast Atom Bombardment Mass Spectrometry: . . . CO.sub.2 DADS", J. Nucl. Med. 23:353-55 (1983).
Davison, A. et al., "A Tetradentate Ligand Designed Specifically to Coordinate Technetium", J. Nucl. Med., 20:6, p. 641 (1979).
Jones, A. et al., "Oxotechnetium Complexes Containing TcON.sub.2 S.sub.2 Cores", Fourth International Symp. on Radiopharmaceutical Chem. p. 333 Aug. 23-27, 1982).
Davison, A. et al., "A Series of Oxotechnetium (+5)Chelate Complexes Containing a TcOS.sub.2 N.sub.2 Core", J. Nucl. Med., 22:6, pp. 57-58 (1981).
Davison Alan
Jones Alun G.
Lister-James John
Bronstein Sewall P.
Children's Medical Center Corp.
Eisenstein Ronald I.
Massachusetts Institute of Technology
Neuner George W.
LandOfFree
Technetium radiodiagnostic fatty acids derived from bisamide bis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium radiodiagnostic fatty acids derived from bisamide bis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium radiodiagnostic fatty acids derived from bisamide bis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1057468